Autolus Therapeutics plc
AUTL- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001730463
In the last 90 days, Autolus Therapeutics plc insiders filed 0 open-market purchases and 1 sale; 83 institutions reported holding it in 13F filings for Q2 2026, worth $212.0M in total; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding Autolus Therapeutics plc changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 69 | 71 | +2 |
| Shares | 109.4M | 110.8M | +1.37M (+1.3%) |
| Value | $260.4M | $258.1M | −$2.21M (−0.8%) |
New holders (10)
Institutions that held Autolus Therapeutics plc at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Lynx1 Capital Management LP | 1,363,025 | $3.18M | 2.10% |
| Schonfeld Strategic Advisors LLC | 291,433 | $679.0K | 0.01% |
| Rathbone Brothers plc | 73,300 | $170.8K | 0.00% |
| Trust Co of Toledo NA | 36,265 | $84.5K | 0.02% |
| Ewa, LLC | 18,317 | $67.0K | 0.04% |
| Simplex Trading, LLC | 18,027 | $42.0K | 0.00% |
| Virtu Financial LLC | 13,880 | $32.0K | 0.00% |
| BNP Paribas Arbitrage, SA | 976 | $2.27K | 0.00% |
| NBC Securities, Inc. | 800 | $1.00K | 0.00% |
| Cornerstone Planning Group LLC | 100 | $233 | 0.00% |
Sold out (8)
Institutions that held Autolus Therapeutics plc at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Nantahala Capital Management, LLC | 4,272,203 | $10.2M |
| Odey Asset Management LLP | 658,995 | $1.57M |
| Citadel Advisors LLC | 185,815 | $442.2K |
| Edentree Asset Management Ltd | 180,000 | $430.2K |
| Mariner, LLC | 101,000 | $240.0K |
| Marshall Wace, LLP | 25,496 | $60.7K |
| State of Wyoming | 300 | $714 |
| Northwestern Mutual Wealth Management Co | 100 | $238 |